Natera (NTRA) : 10-year performance

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis,  Anora products of conception (POC) and non-invasive paternity testing (PAT). 

Founded by Matthew Rabinowitz and Jonathan Sheena in 2003

Headquartered in Austin, TX

Ticker: NTRA

 

 

 

  

Natera is a global leader in cell-free DNA testing. The mission of the Company is to change the management of disease worldwide. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California. The Company offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, researchers in cancer including bio pharmaceutical companies and genetic laboratories through its cloud-based software platform.